Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah M Ivester

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|May 13, 2025
Mystery machine: the complex roles of NLRX1 in viral infectionMackenzie K Woolls, Carley M Elliott, Hannah M Ivester, et al.
Cells|May 28, 2022
Detecting DNA: An Overview of DNA Recognition by Inflammasomes and Protection against Bacterial Respiratory InfectionsJuselyn D Tupik, Justin W Markov Madanick, Hannah M Ivester, et al.
Methods in Cell Biology|April 3, 2022
Methods to evaluate virus-mediated acute lung inflammationHannah M Ivester, Juselyn D Tupik, Margaret A Nagai-Singer, et al.
Immunological Reviews|January 29, 2025
Innate Immunity Never "NODs" Off: NLRs Regulate the Host Anti-Viral Immune ResponseMackenzie K Woolls, Madeline D Mott, Cassandra S Poole, et al.
Frontiers in Allergy|September 11, 2023
Expression profiling identifies key genes and biological functions associated with eosinophilic esophagitis in human patientsHolly A Morrison, Kacie J Hoyt, Christina Mounzer, et al.
Viruses|July 2, 2021
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent MannerVictoria Callahan, Seth Hawks, Matthew A Crawford, et al.
Respiratory Research|October 29, 2025
The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 miceRuben M L Colunga-Biancatelli, Pavel A Solopov, Caitlin M Woodson, et al.
Journal of Medical Virology|January 19, 2023
A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infectionAnna M Hassebroek, Harini Sooryanarain, Connie L Heffron, et al.
JCI Insight|December 3, 2024
Repurposing of lonafarnib as a treatment for SARS-CoV-2 infectionMohsin Khan, Parker Irvin, Seung Bum Park, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|May 13, 2025
Mystery machine: the complex roles of NLRX1 in viral infectionMackenzie K Woolls, Carley M Elliott, Hannah M Ivester, et al.
Cells|May 28, 2022
Detecting DNA: An Overview of DNA Recognition by Inflammasomes and Protection against Bacterial Respiratory InfectionsJuselyn D Tupik, Justin W Markov Madanick, Hannah M Ivester, et al.
Methods in Cell Biology|April 3, 2022
Methods to evaluate virus-mediated acute lung inflammationHannah M Ivester, Juselyn D Tupik, Margaret A Nagai-Singer, et al.
Immunological Reviews|January 29, 2025
Innate Immunity Never "NODs" Off: NLRs Regulate the Host Anti-Viral Immune ResponseMackenzie K Woolls, Madeline D Mott, Cassandra S Poole, et al.
Frontiers in Allergy|September 11, 2023
Expression profiling identifies key genes and biological functions associated with eosinophilic esophagitis in human patientsHolly A Morrison, Kacie J Hoyt, Christina Mounzer, et al.
Viruses|July 2, 2021
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent MannerVictoria Callahan, Seth Hawks, Matthew A Crawford, et al.
Respiratory Research|October 29, 2025
The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 miceRuben M L Colunga-Biancatelli, Pavel A Solopov, Caitlin M Woodson, et al.
Journal of Medical Virology|January 19, 2023
A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infectionAnna M Hassebroek, Harini Sooryanarain, Connie L Heffron, et al.
JCI Insight|December 3, 2024
Repurposing of lonafarnib as a treatment for SARS-CoV-2 infectionMohsin Khan, Parker Irvin, Seung Bum Park, et al.
Pageof 1